Side-by-side comparison of AI visibility scores, market position, and capabilities
Scottsdale public safety technology (NASDAQ: AXON); Taser + body cameras + AI evidence management, Carbyne $625M acquisition creates Axon 911 emergency response platform, 18,000+ law enforcement customers competing with Motorola Solutions.
Axon Enterprise, Inc. is a Scottsdale, Arizona-based public safety technology company — publicly traded on NASDAQ (NASDAQ: AXON) as an S&P 500 Industrials component — developing and selling conducted energy weapons (Taser), body-worn cameras, cloud-based digital evidence management, real-time operations software, and AI-driven public safety intelligence solutions to law enforcement agencies, military organizations, and corrections facilities worldwide through approximately 5,000 employees. Axon's Taser electric weapons (used by 18,000+ law enforcement agencies in 107 countries) define the conducted energy weapon category — but Axon has expanded beyond hardware into a comprehensive cloud-based public safety software platform: Axon Evidence (body camera video storage, evidence management, and prosecutorial disclosure), Axon Records (digital police reports), Axon Dispatch (AI-assisted dispatch), and Axon Draft One (AI-generated use-of-force reports from body camera audio). In a landmark 2025 expansion, Axon announced a $625 million cash acquisition of Carbyne — an emergency communications platform serving 250+ million people worldwide through next-generation 911 call routing, real-time location data, and AI dispatch situational intelligence — creating Axon 911, an integrated emergency response platform combining cloud-native 911 call management with AI-powered context delivery for dispatchers and first responders. The Carbyne acquisition is expected to close Q1 2026. CEO Rick Smith — Axon's founder, who invented the first Taser in the early 1990s after losing two childhood friends to gun violence — leads the company's mission-driven expansion into AI-powered public safety technology.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.